Chunjun New Materials (Shenzhen)
A company providing efficient temperature control services for medicine, data center energy conservation, etc.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY200m | Series A | |
| Total Funding | 000k | ||
Chunjun New Materials (Shenzhen) Co., Ltd., established in Shenzhen in 2018, is a high-tech enterprise focused on temperature control materials and solutions. The company has been recognized as a "Specialized and New" small and medium-sized enterprise in Shenzhen. The core of Chunjun's strategy revolves around developing solutions for vertical applications, guided by China's "carbon peak and carbon neutrality" policies.
The General Manager, Tao Tang, holds a Ph.D. in Materials Science from the National University of Singapore and served as a level-one scientist at Singapore's Agency for Science, Technology and Research (A*STAR), bringing over 15 years of polymer material development experience. This background in advanced materials science is foundational to the company's operations. The broader core team possesses extensive experience in new materials development, telecommunications, and the chip industry. Chunjun has successfully completed multiple funding rounds, including an A-round in November 2023 that raised a significant amount for production line expansion and further research and development.
Chunjun's business is structured into three main segments: medical cold chain, data center liquid cooling, and thermal electric coolers (TEC). The company generates revenue through the sale of its advanced material-based products and integrated solutions to clients in these sectors. For the medical cold chain market, under the brand Senmantai (森曼泰), Chunjun provides high-performance passive temperature-controlled transport boxes using phase change materials. These containers can maintain temperatures from -70 to 20 degrees Celsius for 60-150 hours, suitable for transporting sensitive items like mRNA vaccines, blood, and clinical trial samples. The company has established partnerships with major state-owned pharmaceutical companies like Sinopharm Group and Shanghai Pharmaceuticals.
In the data center sector, the "Chunjun Guangleng" (纯钧光冷) brand offers liquid cooling solutions. The company has developed its own immersion cooling fluids that reportedly reduce costs by 40% and improve heat exchange capacity threefold compared to some established competitors. This division addresses the growing need for energy-efficient cooling in data centers, driven by stricter Power Usage Effectiveness (PUE) regulations. The third pillar involves the development of micro-thermoelectric coolers (Micro-TEC), targeting high-power, miniaturized applications in 5G communications, optical modules, and automotive radar, aiming to provide a domestic alternative to technologies currently dominated by international firms.
Keywords: temperature control materials, thermal management, phase change materials, medical cold chain logistics, vaccine transport, data center cooling, immersion liquid cooling, thermoelectric coolers, TEC, new materials, advanced materials, energy efficiency, carbon neutrality, high-tech enterprise, polymer science, thermal solutions, PUE reduction, pharmaceutical logistics, semiconductor cooling, specialized and new enterprise